Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
John Harry III Cross Insider Profile
4 Followers
John Harry III Cross, CFO at Sonnet BioTherapeutics Holdings, holds 1.59K shares in Sonnet BioTherapeutics Holdings (Ticker: SONN).
John Harry III Cross has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of John Harry III Cross's holdings
Insider Roles
CFO
Roles that John Harry III Cross holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by John Harry III Cross
John Harry III Cross's Trading History
List of latest transactions for each holding click on a transaction to see John Harry III Cross's performance on stock
You May Also Like
John Harry III Cross insider profile FAQ
What is the percentage of profitable transactions made by John Harry III Cross?
The percentage of profitable transactions made by John Harry III Cross is ―.
What is the average return per transaction made by John Harry III Cross?
The average return per transaction made by John Harry III Cross is ―.
What stocks does John Harry III Cross hold?
John Harry III Cross holds: SONN stocks.
What was John Harry III Cross’s latest transaction?
John Harry III Cross latest transaction was an Uninformative Sell of ―.
What was John Harry III Cross's most profitable transaction?
John Harry III Cross’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is John Harry III Cross's role in Sonnet BioTherapeutics Holdings?
John Harry III Cross's role in Sonnet BioTherapeutics Holdings is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.